Human telomerase acts as a hTR-independent reverse transcriptase in mitochondria NK Sharma, A Reyes, P Green, MJ Caron, MG Bonini, DM Gordon, IJ Holt, ... Nucleic acids research 40 (2), 712-725, 2012 | 198 | 2012 |
Intrinsic mitochondrial DNA repair defects in Ataxia Telangiectasia NK Sharma, M Lebedeva, T Thomas, OA Kovalenko, JD Stumpf, ... DNA repair 13, 22-31, 2014 | 77 | 2014 |
Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance P Nilendu, SC Sarode, D Jahagirdar, I Tandon, S Patil, GS Sarode, JK Pal, ... Cellular oncology 41, 353-367, 2018 | 70 | 2018 |
Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics H Patel, P Nilendu, D Jahagirdar, JK Pal, NK Sharma Cancer Biology & Therapy 19 (1), 3-12, 2018 | 68 | 2018 |
In vitro antioxidant potential evaluation of Euphorbia hirta L NK Sharma, S Dey, R Prasad Pharmacologyonline 1, 91-98, 2007 | 63 | 2007 |
Cationic Bioactive Peptide from the Seeds of Benincasa hispida S Sharma, HN Verma, NK Sharma International Journal of Peptides 2014 (1), 156060, 2014 | 59 | 2014 |
Molecular avenues in targeted doxorubicin cancer therapy S Roychoudhury, A Kumar, D Bhatkar, NK Sharma Future Oncology 16 (11), 687-700, 2020 | 51 | 2020 |
Telomerase impinges on the cellular response to oxidative stress through mitochondrial ROS-mediated regulation of autophagy PD Green, NK Sharma, JH Santos International journal of molecular sciences 20 (6), 1509, 2019 | 51 | 2019 |
Breast cancer stem cells as last soldiers eluding therapeutic burn: a hard nut to crack P Nilendu, A Kumar, A Kumar, JK Pal, NK Sharma International journal of cancer 142 (1), 7-17, 2018 | 39 | 2018 |
Extrachromosomal circular DNAs: an extra piece of evidence to depict tumor heterogeneity I Tandon, R Pal, JK Pal, NK Sharma Future science OA 5 (6), FSO390, 2019 | 33 | 2019 |
Molecular approaches to potentiate cisplatin responsiveness in carcinoma therapeutics A Jain, D Jahagirdar, P Nilendu, NK Sharma Expert Review of Anticancer Therapy 17 (9), 815-825, 2017 | 27 | 2017 |
Nitric oxide down-regulates topoisomerase I and induces camptothecin resistance in human breast MCF-7 tumor cells NK Sharma, A Kumar, A Kumari, EJ Tokar, MP Waalkes, CD Bortner, ... PloS one 10 (11), e0141897, 2015 | 27 | 2015 |
Are oral manifestations related to SARS-CoV-2 mediated hemolysis and anemia? GS Sarode, SC Sarode, AR Gadbail, S Gondivkar, NK Sharma, S Patil Medical hypotheses 146, 110413, 2021 | 26 | 2021 |
EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions S Varadarajan, TM Balaji, SC Sarode, GS Sarode, NK Sharma, ... Medical hypotheses 143, 110089, 2020 | 22 | 2020 |
Non-homologous end joining inhibitor SCR-7 to exacerbate low-dose doxorubicin cytotoxicity in HeLa cells A Kumar, D Bhatkar, D Jahagirdar, NK Sharma Journal of Cancer Prevention 22 (1), 47, 2017 | 22 | 2017 |
Distinct regulatory programs control the latent regenerative potential of dermal fibroblasts during wound healing S Abbasi, S Sinha, E Labit, NL Rosin, G Yoon, W Rahmani, A Jaffer, ... Cell Stem Cell 28 (3), 581-583, 2021 | 20 | 2021 |
Recent trends in predictive biomarkers for determining malignant potential of oral potentially malignant disorders GS Sarode, SC Sarode, N Maniyar, N Sharma, S Yerwadekar, S Patil Oncology Reviews 13 (2), 2019 | 20 | 2019 |
Export of microRNAs: a bridge between breast carcinoma and their neighboring cells D Jahagirdar, S Purohit, A Jain, NK Sharma Frontiers in oncology 6, 147, 2016 | 18 | 2016 |
A novel method to detect intracellular metabolite alterations in MCF-7 cells by doxorubicin induced cell death A Kumar, S Patel, D Bhatkar, SC Sarode, NK Sharma Metabolomics 17, 1-16, 2021 | 15 | 2021 |
Biological behavior of oral squamous cell carcinoma in the background of novel corona virus infection SC Sarode, GS Sarode, N Sengupta, NK Sharma, S Patil Oral Oncology 110, 104781, 2020 | 14 | 2020 |